Navigation Links
New Scan 'Sees' Tumors Deep Inside Body
Date:4/2/2008

Imaging technique could help surgeons remove all cancerous tissue

WEDNESDAY, April 2 (HealthDay News) -- Stanford University researchers have developed a new imaging system that illuminates tumors deep inside the body and lets doctors view details 1,000 times smaller than previously possible.

Raman spectroscopy uses tiny nanoparticles injected into the body to serve as beacons for lasers, according to a description the method published in this week's online issue of the Proceedings of the National Academy of Sciences.

When a laser beam outside the body hits them, the specialized particles emit signals that can be converted into a visible indicator of their location in the body. These strong, long-lived signals can simultaneously transmit information about multiple molecular targets.

"Usually we can measure one or two things at a time," senior author Dr. Sanjiv Sam Gambhir, a professor of radiology at Stanford's School of Medicine, said in a prepared statement. "With this, we can now likely see 10, 20, 30 things at once."

The new system utilizes the Raman effect, which occurs when light is shined on an object. The light causes roughly one in 10 million photons to bounce off the object's molecules with an increase or decrease in energy, called Raman scattering. This forms a unique measurable pattern, called a spectral fingerprint, for each type of molecule.

The Stanford research team tested the system on mice, injecting them with various engineered Raman nanoparticles and then viewing the anesthetized mice under a special microscope where they were exposed to laser light. The nanoparticles, for example, would be "tagged" with different pieces of proteins that sought out different tumor molecules.

In these experiments, the team spotted targets 1,000 times smaller than what is viewable with the most precise fluorescence imaging available. Since the Raman effect lasts indef
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Hypnosis for smoking cessation sees strong results
2. Chemmart(R) Sees Instant Results From Launch of New Rewards Program
3. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
4. Study suggests brain tumors need treatment with multiple targeted drugs
5. Bright tumors, dim prospects
6. Genomic profiling of lung tumors helps doctors choose most effective treatment
7. Gene Tests Match Up Lung Tumors, Best Treatment
8. Endoscopic resection is a safe and effective treatment for gastrointestinal smooth muscle tumors
9. New seed therapy helps pinpoint breast tumors with more accuracy
10. Study suggests existing drugs may be useful in treating brain tumors
11. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Scan 'Sees' Tumors Deep Inside Body
(Date:8/22/2014)... Back-to-school time provides an opportunity for parents to develop ... an expert suggests. "Forget New Year,s resolutions; the ... the start of a new fitness and exercise program ... the University of the Sciences in Philadelphia, said in ... likely to build up, "it,s important for mom and ...
(Date:8/22/2014)... attained the distinguished Magnet hospital designation by the ... Considered the gold standard for nursing excellence, the ... professionalism. It is the top international credential for ... Newport Hospital was based on the hospital,s continued ... , "It is a privilege for us to ...
(Date:8/22/2014)... FRIDAY, Aug. 22, 2014 (HealthDay News) -- Many children ... a vaccination, but there are a number of ways ... kids, an expert suggests. The first step is ... the vaccinations help protect their health, said Rita John, ... at Columbia University School of Nursing in New York ...
(Date:8/22/2014)... Women with severe disabilities and multiple chronic conditions ... with no disabilities or no chronic conditions, a new ... often than women with moderate disabilities or women with ... an affiliate scientist with the Li Ka Shing Knowledge ... women with disabilities often have other measures of social ...
(Date:8/22/2014)... Clearwater, FL (PRWEB) August 22, 2014 ... Sauces continues expansion of products in providing new recipe ... for casual wear. , Hailing from Clearwater, Florida, ... would appreciate having 1 card with two to three ... to the recipes on the website. ...
Breaking Medicine News(10 mins):Health News:With Kids in School, Parents Can Work Out 2Health News:Newport Hospital receives nursing's highest credential for third time with Magnet recognition 2Health News:Simple Steps Make Shots Less Scary for Kids, Nurse Says 2Health News:Women with severe, chronic health issues are screened for breast cancer less often 2Health News:Pirate Jonny's Caribbean BBQ Rubs, Seasonings & Sauces Get New Look by Hoisting New Recipe Card Creations and New Clothing Apparel for its Logos 2
... STERIS Corporation (NYSE:, STE ) today announced ... Drug,Administration (FDA) a new liquid chemical sterilization system for ... FDA regarding,issues raised in a May 2008 warning letter ... The new liquid chemical sterilization system,submitted to the FDA ...
... difficulty obtaining credit for capital expenditures, according to Millennium ... Research Group,s (MRG,s) US Markets for Video and ... face increased difficulty obtaining credit at favorable terms to ... US economic crisis. With the economic crisis expected ...
... They are soaked with drugs to target only the ... News) -- A minimally invasive therapy that uses beads ... liver tumors, according to new studies. , ... Microspheres, or beads, combined with cancer-killing chemotherapeutic agents are ...
... manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., sent the first letter below, dated November 29, 2008, ... letter below, dated January 9, 2009, was sent to the Board. ... ... , ...
... Society for Technology in Anesthesia Annual Meeting Quantifies ... Improved ICU UtilizationIRVINE, Calif., Jan. 20 Masimo ... Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion ... clinicians at Dartmouth-Hitchcock Medical Center (DHMC) presented new ...
... Staple Ensures Successful and Productive Call Centers are Created with Used ... ... 2009 -- www.thefsi.com --The Furniture Source, provider of new ... Twin Cities-based call centers enhance the success of their business by ...
Cached Medicine News:Health News:STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter 2Health News:STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter 3Health News:STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter 4Health News:STERIS Corporation Submits New Sterilization System To FDA and Announces Developments on SYSTEM 1 Warning Letter 5Health News:Spending on Integrated Operating Rooms to Slow in 2009, But Expected to Recover in 2010 2Health News:Tiny Chemo Beads Boost Liver Cancer Outcomes 2Health News:Tiny Chemo Beads Boost Liver Cancer Outcomes 3Health News:Xmark Sends Letters to Icagen's Board of Directors: Questions Company's Leadership as Well as Motives Behind Adoption of Poison Pill 2Health News:Xmark Sends Letters to Icagen's Board of Directors: Questions Company's Leadership as Well as Motives Behind Adoption of Poison Pill 3Health News:Xmark Sends Letters to Icagen's Board of Directors: Questions Company's Leadership as Well as Motives Behind Adoption of Poison Pill 4Health News:Xmark Sends Letters to Icagen's Board of Directors: Questions Company's Leadership as Well as Motives Behind Adoption of Poison Pill 5Health News:Xmark Sends Letters to Icagen's Board of Directors: Questions Company's Leadership as Well as Motives Behind Adoption of Poison Pill 6Health News:Xmark Sends Letters to Icagen's Board of Directors: Questions Company's Leadership as Well as Motives Behind Adoption of Poison Pill 7Health News:Xmark Sends Letters to Icagen's Board of Directors: Questions Company's Leadership as Well as Motives Behind Adoption of Poison Pill 8Health News:Xmark Sends Letters to Icagen's Board of Directors: Questions Company's Leadership as Well as Motives Behind Adoption of Poison Pill 9Health News:Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care 2Health News:Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care 3Health News:Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care 4Health News:Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care 5Health News:Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care 6Health News:Clinicians at Dartmouth-Hitchcock Medical Center Present New Data Showing Masimo Rainbow SET(R) Oximetry and Patient SafetyNet(TM) Improves Patient Outcomes and Reduces the Cost of Care 7Health News:Used Cubicles from The Furniture Source Help to Eliminate Cubicle Claustrophobia in Call Centers 2
(Date:8/22/2014)...  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the ... common stock and warrants at a price of $10,000 ... to deducting underwriting discounts and commissions and offering expenses ... immediately separable and will be issued separately.  The shares ... The NASDAQ Stock Market under the ticker symbol "WGBS" ...
(Date:8/21/2014)... 2014  eRelevance Corporation ( www.erelevancecorp.com ), a ... it has completed integration with Nextech, a popular ... and Dermatology practices. "Integration allows our ... practices using Nextech," stated Bob Fabbio , ... from the EMR we are able to automatically ...
(Date:8/21/2014)... BURLINGTON, Mass. , Aug. 21, 2014 /PRNewswire/ ... of COPD,  physicians in Brazil ... to follow clinical guidelines and commonly prescribe long-acting ... regimens, although they do so within current severe ... combinations (FDCs) that are expected to launch in ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3
... of trial triggers $10 million milestone payment to PharmassetPRINCETON, ... VRUS ) and Roche (Roche SWX: RO, ROG; Pink ... been dosed in a Phase IIb study of R7128, ... the treatment of chronic hepatitis C (HCV). The trial ...
... to Initiate in 2010 for BlinatumomabNEW YORK, April 24 ... biopharmaceutical company developing novel, proprietary antibodies for the treatment ... R&D Day for investors and financial analysts at The ... highlighted significant areas of development across Micromet,s BiTE antibody ...
Cached Medicine Technology:Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 2Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 3Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 4Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 5Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 6Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 7Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 8Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 9Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C 10Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 2Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 3Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: